aspirin has been researched along with nutlin-3a in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, W; Liu, C; Liu, S; Miao, R; Qu, K; Wang, Z; Xu, X | 1 |
| Aslam, M; Awan, MS; Bhatti, AI; Liaquat, A; Liaquat, M | 1 |
2 other study(ies) available for aspirin and nutlin-3a
| Article | Year |
|---|---|
Synergistic effect of nutlin-3 combined with aspirin in hepatocellular carcinoma HepG2 cells through activation of Bcl-2/Bax signaling pathway.
Topics: Animals; Antineoplastic Agents; Apoptosis; Aspirin; bcl-2-Associated X Protein; Carcinoma, Hepatocellular; Caspases; Cell Movement; Drug Synergism; Hep G2 Cells; Humans; Imidazoles; Liver Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Piperazines; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Transplantation, Heterologous; Vascular Endothelial Growth Factor A | 2018 |
Effect of pharmacodynamical interaction between nutlin-3a and aspirin in the activation of p53.
Topics: Apoptosis; Aspirin; Cell Line, Tumor; Humans; Imidazoles; Piperazines; Proto-Oncogene Proteins c-mdm2; Tumor Suppressor Protein p53 | 2021 |